Leveraging Systematic Reviews to Explore Disease Burden and Costs of Per- and Polyfluoroalkyl Substance Exposures in the United States
Accelerating evidence confirms the contribution of per- and polyfluoroalkyl substances (PFAS) to disease burden and disability across the lifespan. Given that policy makers raise the high cost of remediation and of substituting PFAS with safer alternatives in consumer products as barriers to confron...
Saved in:
| Published in: | Exposure and health Vol. 15; no. 2; pp. 373 - 394 |
|---|---|
| Main Authors: | , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Dordrecht
Springer Netherlands
01.06.2023
Springer Nature B.V |
| Subjects: | |
| ISSN: | 2451-9766, 2451-9685 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Accelerating evidence confirms the contribution of per- and polyfluoroalkyl substances (PFAS) to disease burden and disability across the lifespan. Given that policy makers raise the high cost of remediation and of substituting PFAS with safer alternatives in consumer products as barriers to confronting adverse health outcomes associated with PFAS exposure, it is important to document the costs of inaction even in the presence of uncertainty. We therefore quantified disease burdens and related economic costs due to legacy PFAS exposures in the US in 2018. We leveraged systematic reviews and used meta-analytic inputs whenever possible, identified previously published exposure–response relationships, and calculated PFOA- and PFOS-attributable increases in 13 conditions. These increments were then applied to census data to determine total annual PFOA- and PFOS-attributable cases of disease, from which we calculated economic costs due to medical care and lost productivity using previously published cost-of-illness data. We identified PFAS-attributable disease costs in the US of $5.52 billion across five primary disease endpoints shown to be associated with PFAS exposure in meta-analyses. This estimate represented the lower bound, with sensitivity analyses revealing as much as $62.6 billion in overall costs. While further work is needed to assess probability of causation and establish with greater certainty effects of the broader category of PFAS, the results confirm further that public health and policy interventions are still necessary to reduce exposure to PFOA and PFOS and their endocrine-disrupting effects. This study demonstrates the large potential economic implications of regulatory inaction. |
|---|---|
| AbstractList | Accelerating evidence confirms the contribution of per- and polyfluoroalkyl substances (PFAS) to disease burden and disability across the lifespan. Given that policy makers raise the high cost of remediation and of substituting PFAS with safer alternatives in consumer products as barriers to confronting adverse health outcomes associated with PFAS exposure, it is important to document the costs of inaction even in the presence of uncertainty. We therefore quantified disease burdens and related economic costs due to legacy PFAS exposures in the US in 2018. We leveraged systematic reviews and used meta-analytic inputs whenever possible, identified previously published exposure-response relationships, and calculated PFOA- and PFOS-attributable increases in 13 conditions. These increments were then applied to census data to determine total annual PFOA- and PFOS-attributable cases of disease, from which we calculated economic costs due to medical care and lost productivity using previously published cost-of-illness data. We identified PFAS-attributable disease costs in the US of $5.52 billion across five primary disease endpoints shown to be associated with PFAS exposure in meta-analyses. This estimate represented the lower bound, with sensitivity analyses revealing as much as $62.6 billion in overall costs. While further work is needed to assess probability of causation and establish with greater certainty effects of the broader category of PFAS, the results confirm further that public health and policy interventions are still necessary to reduce exposure to PFOA and PFOS and their endocrine-disrupting effects. This study demonstrates the large potential economic implications of regulatory inaction.Accelerating evidence confirms the contribution of per- and polyfluoroalkyl substances (PFAS) to disease burden and disability across the lifespan. Given that policy makers raise the high cost of remediation and of substituting PFAS with safer alternatives in consumer products as barriers to confronting adverse health outcomes associated with PFAS exposure, it is important to document the costs of inaction even in the presence of uncertainty. We therefore quantified disease burdens and related economic costs due to legacy PFAS exposures in the US in 2018. We leveraged systematic reviews and used meta-analytic inputs whenever possible, identified previously published exposure-response relationships, and calculated PFOA- and PFOS-attributable increases in 13 conditions. These increments were then applied to census data to determine total annual PFOA- and PFOS-attributable cases of disease, from which we calculated economic costs due to medical care and lost productivity using previously published cost-of-illness data. We identified PFAS-attributable disease costs in the US of $5.52 billion across five primary disease endpoints shown to be associated with PFAS exposure in meta-analyses. This estimate represented the lower bound, with sensitivity analyses revealing as much as $62.6 billion in overall costs. While further work is needed to assess probability of causation and establish with greater certainty effects of the broader category of PFAS, the results confirm further that public health and policy interventions are still necessary to reduce exposure to PFOA and PFOS and their endocrine-disrupting effects. This study demonstrates the large potential economic implications of regulatory inaction.The online version contains supplementary material available at 10.1007/s12403-022-00496-y.Supplementary InformationThe online version contains supplementary material available at 10.1007/s12403-022-00496-y. Accelerating evidence confirms the contribution of per- and polyfluoroalkyl substances (PFAS) to disease burden and disability across the lifespan. Given that policy makers raise the high cost of remediation and of substituting PFAS with safer alternatives in consumer products as barriers to confronting adverse health outcomes associated with PFAS exposure, it is important to document the costs of inaction even in the presence of uncertainty. We therefore quantified disease burdens and related economic costs due to legacy PFAS exposures in the US in 2018. We leveraged systematic reviews and used meta-analytic inputs whenever possible, identified previously published exposure–response relationships, and calculated PFOA- and PFOS-attributable increases in 13 conditions. These increments were then applied to census data to determine total annual PFOA- and PFOS-attributable cases of disease, from which we calculated economic costs due to medical care and lost productivity using previously published cost-of-illness data. We identified PFAS-attributable disease costs in the US of $5.52 billion across five primary disease endpoints shown to be associated with PFAS exposure in meta-analyses. This estimate represented the lower bound, with sensitivity analyses revealing as much as $62.6 billion in overall costs. While further work is needed to assess probability of causation and establish with greater certainty effects of the broader category of PFAS, the results confirm further that public health and policy interventions are still necessary to reduce exposure to PFOA and PFOS and their endocrine-disrupting effects. This study demonstrates the large potential economic implications of regulatory inaction. Accelerating evidence confirms the contribution of per- and polyfluoroalkyl substances (PFAS) to disease burden and disability across the lifespan. Given that policy makers raise the high cost of remediation and of substituting PFAS with safer alternatives in consumer products as barriers to confronting adverse health outcomes associated with PFAS exposure, it is important to document the costs of inaction even in the presence of uncertainty. We therefore quantified disease burdens and related economic costs due to legacy PFAS exposures in the US in 2018. We leveraged systematic reviews and used meta-analytic inputs whenever possible, identified previously published exposure-response relationships, and calculated PFOA- and PFOS-attributable increases in 13 conditions. These increments were then applied to census data to determine total annual PFOA- and PFOS-attributable cases of disease, from which we calculated economic costs due to medical care and lost productivity using previously published cost-of-illness data. We identified PFAS-attributable disease costs in the US of $5.52 billion across five primary disease endpoints shown to be associated with PFAS exposure in meta-analyses. This estimate represented the lower bound, with sensitivity analyses revealing as much as $62.6 billion in overall costs. While further work is needed to assess probability of causation and establish with greater certainty effects of the broader category of PFAS, the results confirm further that public health and policy interventions are still necessary to reduce exposure to PFOA and PFOS and their endocrine-disrupting effects. This study demonstrates the large potential economic implications of regulatory inaction. The online version contains supplementary material available at 10.1007/s12403-022-00496-y. |
| Author | Obsekov, Vladislav Trasande, Leonardo Kahn, Linda G. |
| Author_xml | – sequence: 1 givenname: Vladislav surname: Obsekov fullname: Obsekov, Vladislav organization: Department of Pediatrics, NYU Grossman School of Medicine – sequence: 2 givenname: Linda G. surname: Kahn fullname: Kahn, Linda G. organization: Department of Pediatrics, NYU Grossman School of Medicine, Department of Population Health, NYU Grossman School of Medicine – sequence: 3 givenname: Leonardo orcidid: 0000-0002-1928-597X surname: Trasande fullname: Trasande, Leonardo email: leonardo.trasande@nyulangone.org organization: Department of Pediatrics, NYU Grossman School of Medicine, Department of Population Health, NYU Grossman School of Medicine, Department of Environmental Health, NYU Grossman School of Medicine, NYU Wagner School of Public Service, NYU School of Global Public Health |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37213870$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9UstuEzEUtVARLaU_wAJZYsNmwI8Zz3iFIJSHFImK0LXlce6kLo4dbE9gfoDvxmkaHl105Wvfc47Ptc9jdOSDB4SeUvKSEtK-SpTVhFeEsYqQWopqeoBOWN3QSoquOTrUrRDH6Cyla0IIFQ0trEfomLeM8q4lJ-jXHLYQ9cr6FV5MKcNaZ2vwF9ha-JFwDvj858aFCPidTaAT4LdjXILH2i_xLKSccBjwBcTq5uQiuGlwY4hBu2-Tw4uxT1l7AzuZkMYICVuP8xXgS28zLPEi6wzpCXo4aJfg7HY9RZfvz7_OPlbzzx8-zd7MK9PUNFcwcCB0AGjMIFuqqSGGwwCyNr0xZd8PtJc9p0IaoWmZmAlBSa8FyKaWwE_R673uZuzXsDTgc9RObaJd6zipoK36v-PtlVqFrSpasutqVhRe3CrE8H2ElNXaJgPOaQ9hTIp1tG1bWW4u0Od3oNdhjL7Mp5hkhPGWd3VBPfvX0h8vhz8qgG4PMDGkFGFQxpZHs2Hn0LpiTe0SofaJUCUR6iYRaipUdod6UL-XxPekVMB-BfGv7XtYvwEgE8uT |
| CitedBy_id | crossref_primary_10_3390_ani13182923 crossref_primary_10_1016_j_oneear_2023_07_001 crossref_primary_10_1111_joim_13748 crossref_primary_10_1016_j_resconrec_2025_108524 crossref_primary_10_1038_s41591_025_03697_5 crossref_primary_10_3390_ijms24054338 crossref_primary_10_1080_10408444_2024_2415893 crossref_primary_10_1007_s00216_025_05902_3 crossref_primary_10_1016_j_scitotenv_2025_180003 crossref_primary_10_1038_s41574_023_00872_x crossref_primary_10_1056_NEJMp2303333 crossref_primary_10_1186_s12302_023_00721_8 crossref_primary_10_1016_j_scitotenv_2024_170647 crossref_primary_10_1039_D5EM00238A crossref_primary_10_3389_fnut_2024_1290680 crossref_primary_10_1016_j_envint_2024_108860 crossref_primary_10_1360_CSB_2025_0225 crossref_primary_10_1371_journal_pone_0294134 crossref_primary_10_1016_j_gsd_2025_101465 crossref_primary_10_1016_j_scitotenv_2025_180502 crossref_primary_10_1016_j_anai_2024_06_029 crossref_primary_10_1057_s41271_025_00594_6 crossref_primary_10_1016_j_jes_2025_06_048 crossref_primary_10_2208_jscejj_24_00257 crossref_primary_10_1111_gwmr_70000 crossref_primary_10_1210_jendso_bvad141 crossref_primary_10_1210_jendso_bvad163 crossref_primary_10_3390_catal12121572 crossref_primary_10_1016_j_ijheh_2024_114509 |
| Cites_doi | 10.1016/j.envres.2020.110690 10.1210/jc.2013-1282 10.1016/j.fertnstert.2014.10.001 10.1016/j.fertnstert.2014.10.011 10.1016/j.envint.2018.12.041 10.1186/s12940-017-0338-x 10.1093/aje/kwh275 10.1080/10408444.2016.1182117 10.1080/10408398.2021.1903382 10.1289/ehp.0800408 10.1016/j.envint.2019.05.045 10.1289/ehp.0901252 10.1177/1048291115590506 10.1016/j.ijheh.2012.03.004 10.1289/EHP6785 10.1371/journal.pmed.1002502 10.1159/000452660 10.1542/peds.2014-0063 10.1210/jc.2013-2409 10.1021/acs.estlett.0c00713 10.1080/13696998.2021.1900202 10.1097/EDE.0000000000000903 10.3390/ijerph15091832 10.1289/ehp.1307893 10.1210/jc.2003-032046 10.1186/s12940-017-0269-6 10.1016/j.jclinepi.2018.11.024 10.1080/10962247.2021.1909668 10.6027/TN2019-516 10.1016/j.envint.2020.106125 10.1007/s40273-019-00824-2 10.1289/ehp.10598 10.3390/ijerph15102070 10.1080/10643389.2019.1614848 10.1210/jc.2005-0628 10.1016/S2213-8587(20)30129-7 10.1002/cam4.318 10.1186/s12940-020-00591-0 10.1056/NEJMoa1405870 10.1056/NEJMp1405158 10.3109/10408444.2014.952400 10.1016/S2213-8587(16)30275-3 10.1186/s13643-020-01490-8 10.1371/journal.pone.0197244 10.1515/reveh-2020-0049 10.1016/j.amepre.2013.04.017 10.1093/humupd/dmaa037 10.1097/EDE.0b013e31826cc0cf 10.1021/acs.est.1c03565 10.1001/jama.2011.2034 10.1093/humrep/dem046 10.1289/ehp.11064 10.3390/ijerph14070691 10.1016/j.jclinepi.2015.06.005 10.1016/j.fertnstert.2015.10.032 10.1093/pubmed/fdt071 10.2105/AJPH.2005.068874 10.1016/j.jhealeco.2011.10.003 10.1186/1472-6823-14-86 10.1038/s41370-021-00316-6 10.1002/cncr.21824 10.1289/ehp.1510046 10.1503/cmaj.101715 10.1289/ehp.1307923 10.1289/ehp.1307177 10.1016/j.chemosphere.2006.12.031 10.1097/EDE.0b013e31823b5031 10.1186/s12913-018-3529-4 10.1016/j.ijheh.2017.11.004 10.1210/jcem.87.2.8182 10.1289/EHP2619 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2022 The Author(s) 2022. The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2022 – notice: The Author(s) 2022. – notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION NPM 8C1 8FE 8FH ABUWG AEUYN AFKRA ATCPS AZQEC BBNVY BENPR BHPHI BKSAR CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ LK8 M7P PATMY PCBAR PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PYCSY 7X8 5PM |
| DOI | 10.1007/s12403-022-00496-y |
| DatabaseName | Springer Nature Link CrossRef PubMed Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central ProQuest One Sustainability ProQuest Central UK/Ireland Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Earth, Atmospheric & Aquatic Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Biological Science Collection Biological Science Database Environmental Science Database Earth, Atmospheric & Aquatic Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China Environmental Science Collection MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China Earth, Atmospheric & Aquatic Science Collection ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Agricultural & Environmental Science Collection Biological Science Collection ProQuest Central (New) ProQuest Public Health ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Earth, Atmospheric & Aquatic Science Database Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Environmental Science Collection ProQuest One Academic UKI Edition Environmental Science Database ProQuest One Academic ProQuest One Academic (New) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic CrossRef PubMed ProQuest Central Student |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health Economics |
| EISSN | 2451-9685 |
| EndPage | 394 |
| ExternalDocumentID | PMC10198842 37213870 10_1007_s12403_022_00496_y |
| Genre | Journal Article |
| GeographicLocations | United States--US |
| GeographicLocations_xml | – name: United States--US |
| GrantInformation_xml | – fundername: National Institutes of Health grantid: ES033423; ES000260; ES030403 funderid: http://dx.doi.org/10.13039/100000002 – fundername: NIEHS NIH HHS grantid: K99 ES030403 – fundername: NIEHS NIH HHS grantid: R00 ES030403 – fundername: NIEHS NIH HHS grantid: P30 ES000260 – fundername: ; grantid: ES033423; ES000260; ES030403 |
| GroupedDBID | -EM 0R~ 2JY 2KG 2LR 406 53G 8C1 AACDK AAHNG AAIAL AAJBT AAJKR AANZL AARHV AASML AATNV AATVU AAUYE AAYIU AAYTO AAYZH AAZMS ABAKF ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABMQK ABPLI ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABUWG ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACPIV ACZOJ ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGNC AEJHL AEJRE AEKMD AEMSY AESKC AEUYN AEVLU AEXYK AFBBN AFKRA AFLOW AFQWF AFRAH AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGRTI AGWZB AGYKE AHBYD AHSBF AHYZX AIAKS AIGIU AILAN AITGF AJBLW AJRNO AJZVZ ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF AOCGG ATCPS AXYYD BBNVY BENPR BGNMA BHPHI BKSAR C6C CCPQU CSCUP DDRTE DNIVK DPUIP EBLON EBS EIOEI EJD FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FYUFA GGCAI H13 HCIFZ IKXTQ IWAJR IXD J-C JZLTJ KOV LLZTM M4Y M7P NPVJJ NQJWS NU0 O9J PATMY PCBAR PT4 PYCSY R89 ROL RSV SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE TSG UKHRP UOJIU UTJUX UZXMN VFIZW Z85 ZMTXR AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC AEZWR AFDZB AFFHD AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY PQGLB AHAVH NPM 8FE 8FH AZQEC DWQXO GNUQQ LK8 PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c541t-ef3e01fee5cf971a1c0c3efe94cbcc1a1bf1b9b3169c6a101626610ba6e9549e3 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 40 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000831008200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2451-9766 |
| IngestDate | Tue Nov 04 02:07:38 EST 2025 Thu Jul 10 23:48:29 EDT 2025 Tue Dec 02 16:07:23 EST 2025 Thu Apr 03 07:01:10 EDT 2025 Tue Nov 18 20:48:38 EST 2025 Sat Nov 29 02:56:44 EST 2025 Fri Feb 21 02:44:33 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Reproductive health Obesity Polyfluoroalkyl substances Respiratory infection Metabolism PFAS Disease burden Fertility Child health Perfluoroalkyl substances Economic costs Diabetes Environmental chemicals Cancer |
| Language | English |
| License | The Author(s) 2022. Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c541t-ef3e01fee5cf971a1c0c3efe94cbcc1a1bf1b9b3169c6a101626610ba6e9549e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-1928-597X |
| OpenAccessLink | https://link.springer.com/10.1007/s12403-022-00496-y |
| PMID | 37213870 |
| PQID | 2920237384 |
| PQPubID | 2044162 |
| PageCount | 22 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10198842 proquest_miscellaneous_2817779162 proquest_journals_2920237384 pubmed_primary_37213870 crossref_citationtrail_10_1007_s12403_022_00496_y crossref_primary_10_1007_s12403_022_00496_y springer_journals_10_1007_s12403_022_00496_y |
| PublicationCentury | 2000 |
| PublicationDate | 2023-06-01 |
| PublicationDateYYYYMMDD | 2023-06-01 |
| PublicationDate_xml | – month: 06 year: 2023 text: 2023-06-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Dordrecht |
| PublicationPlace_xml | – name: Dordrecht – name: Netherlands |
| PublicationTitle | Exposure and health |
| PublicationTitleAbbrev | Expo Health |
| PublicationTitleAlternate | Expo Health |
| PublicationYear | 2023 |
| Publisher | Springer Netherlands Springer Nature B.V |
| Publisher_xml | – name: Springer Netherlands – name: Springer Nature B.V |
| References | Ding (CR30) 2017 Eick, Goin, Chartres, Lam, Woodruff (CR31) 2020; 9 Crawford, Boulet, Mneimneh, Perkins, Jamieson, Zhang (CR28) 2016; 105 Bach, Bech, Brix, Nohr, Bonde, Henriksen (CR8) 2015; 45 Whitworth, Haug, Baird, Becher, Hoppin, Skjaerven (CR97) 2012; 23 Johnson, Sutton, Atchley, Koustas, Lam, Sen (CR52) 2014; 122 Meng, Inoue, Ritz, Olsen, Liew (CR68) 2018; 15 Azziz, Marin, Hoq, Badamgarav, Song (CR7) 2005; 90 Kahn, Harley, Siegel, Zhu, Factor-Litvak, Porucznik (CR54) 2021; 27 CR32 Rogers, Reh, Breysse (CR77) 2021; 31 Grandjean, Andersen, Budtz-Jorgensen, Nielsen, Molbak, Weihe (CR41) 2012; 307 Lamerato, Havstad, Gandhi, Jones, Nathanson (CR61) 2006; 106 Rappazzo, Coffman, Hines (CR76) 2017; 14 Malits, Blustein, Trasande, Attina (CR66) 2018; 221 Attina, Malits, Naidu, Trasande (CR5) 2019; 108 Finkelstein, Graham, Malhotra (CR33) 2014; 133 Lam, Koustas, Sutton, Johnson, Atchley, Sen (CR60) 2014; 122 Bach, Vested, Jorgensen, Bonde, Henriksen, Toft (CR10) 2016; 46 CR48 Boivin, Bunting, Collins, Nygren (CR14) 2007; 22 Fryar, Carroll, Ogden (CR34) 2016 Garmendia Madariaga, Santos Palacios, Guillen-Grima, Galofre (CR37) 2014; 99 CR43 CR42 Grandjean, Clapp (CR40) 2015; 25 Bartell, Calafat, Lyu, Kato, Ryan, Steenland (CR12) 2010; 118 Kahn, Philippat, Nakayama, Slama, Trasande (CR53) 2020; 8 Schrenk, Bignami, Bodin, Chipman, Del Mazo, Grasl-Kraupp (CR78) 2020; 18 Zhang, Sundaram, Maisog, Calafat, Barr, Buck Louis (CR101) 2015; 103 Muennig, Lubetkin, Jia, Franks (CR70) 2006; 96 Impinen, Longnecker, Nygaard, London, Ferguson, Haug (CR49) 2019; 124 Gould (CR39) 2009; 117 Tong, Amand, Kieffer, Kyaw (CR86) 2018; 18 Waterfield, Rogers, Grandjean, Auffhammer, Sunding (CR94) 2020; 19 Cawley, Meyerhoefer (CR18) 2012; 31 Liu, Dhana, Furtado, Rood, Zong, Liang (CR64) 2018; 15 CR67 Neumann, Cohen, Weinstein (CR71) 2014; 371 Goldenman, Fernandes, Holland, Tugran, Nordin, Schoumacher (CR38) 2019 Levin (CR63) 1953; 9 Vagi, Azziz-Baumgartner, Sjodin, Calafat, Dumesic, Gonzalez (CR92) 2014; 14 Xu, Fletcher, Pineda, Lindh, Nilsson, Glynn (CR100) 2020; 128 Missmer, Hankinson, Spiegelman, Barbieri, Marshall, Hunter (CR69) 2004; 160 Wielsoe, Kern, Bonefeld-Jorgensen (CR98) 2017; 16 Koustas, Lam, Sutton, Johnson, Atchley, Sen (CR58) 2014; 122 Kormos, Wilkinson, Davey, Cunningham (CR57) 2014; 36 (CR21) 2020 Bartell, Vieira (CR11) 2021; 71 CR72 Fuldeore, Yang, Du, Soliman, Wu, Winkel (CR36) 2015; 103 Lauritzen, Larose, Oien, Sandanger, Odland, van de Bor (CR62) 2018; 17 Holzer, Midasch, Rauchfuss, Kraft, Reupert, Angerer (CR47) 2008; 116 Buck Louis, Peterson, Chen, Hediger, Croughan, Sundaram (CR15) 2012; 23 Wen, Lin, Su, Chen, Lin (CR95) 2013; 98 Wan, Co, El-Nezami (CR93) 2021 Sun, Zong, Valvi, Nielsen, Coull, Grandjean (CR84) 2018; 126 CR89 CR88 Andrews, Naidenko (CR2) 2020; 7 CR87 CR85 Kowlessar, Jiang, Steiner (CR59) 2011 Kim, Moon, Oh, Jung, Ji, Choi (CR55) 2018; 13 Calafat, Wong, Kuklenyik, Reidy, Needham (CR17) 2007; 115 Hollowell, Staehling, Flanders, Hannon, Gunter, Spencer (CR46) 2002; 87 Attina, Hauser, Sathyanarayana, Hunt, Bourguignon, Myers (CR4) 2016; 4 Aberger, Wilson, Holzbeierlein, Griebling, Nangia (CR1) 2014; 3 Hepp, Lage, Espaillat, Gossain (CR44) 2021; 24 CR19 Peterson, Grosse, Li, Sharma, Razzaghi, Herman (CR75) 2015; 212 CR16 Liu, Yang, Wang, Yuan (CR65) 2018 CR13 Whiting, Savović, Higgins, Caldwell, Reeves, Shea (CR96) 2016; 69 Azziz, Woods, Reyna, Key, Knochenhauer, Yildiz (CR6) 2004; 89 Pelch, Reade, Wolffe, Kwiatkowski (CR74) 2019; 130 (CR50) 1981 Crone, Speth, Wahman, Smith, Abulikemu, Kleiner (CR29) 2019; 49 Hill (CR45) 1965; 58 Shih, Xu, Chien, Kim, Shen, Li (CR79) 2019; 37 Cordner, Goldenman, Birnbaum, Brown, Miller, Mueller (CR27) 2021; 55 CR91 CR90 Steenland, Barry, Savitz (CR82) 2018; 29 Williams, Gousen, DeFrances (CR99) 2018 Steenland, Winquist (CR81) 2021; 194 Olsen, Mair, Reagen, Ellefson, Ehresman, Butenhoff (CR73) 2007; 68 Chohan, Petaway, Rivera-Diaz, Day, Colaianni, Keramati (CR26) 2020 Fuldeore, Soliman (CR35) 2017; 82 Jain, Williams, Arnold, Ampofo, Bramley, Reed (CR51) 2015; 372 CR25 CR24 CR23 CR22 Bach, Bech, Nohr, Olsen, Matthiesen, Bonefeld-Jorgensen (CR9) 2016; 124 CR20 Arbuckle, Kubwabo, Walker, Davis, Lalonde, Kosarac (CR3) 2013; 216 Steenland, Fletcher, Stein, Bartell, Darrow, Lopez-Espinosa (CR83) 2020; 145 Knol, Le Cessie, Algra, Vandenbroucke, Groenwold (CR56) 2012; 184 Zhou, Zhang, Hoerger (CR102) 2013; 45 Stahlman, Fan (CR80) 2019; 26 AM Calafat (496_CR17) 2007; 115 PJ Neumann (496_CR71) 2014; 371 EA Finkelstein (496_CR33) 2014; 133 RD Rogers (496_CR77) 2021; 31 CC Bach (496_CR9) 2016; 124 496_CR67 CC Bach (496_CR8) 2015; 45 Institute of Medicine (496_CR50) 1981 TE Arbuckle (496_CR3) 2013; 216 NM Kowlessar (496_CR59) 2011 J Cawley (496_CR18) 2012; 31 HB Lauritzen (496_CR62) 2018; 17 K Steenland (496_CR82) 2018; 29 M Aberger (496_CR1) 2014; 3 S Jain (496_CR51) 2015; 372 A Cordner (496_CR27) 2021; 55 496_CR72 P Whiting (496_CR96) 2016; 69 YT Shih (496_CR79) 2019; 37 JG Hollowell (496_CR46) 2002; 87 T Ding (496_CR30) 2017 A Hill (496_CR45) 1965; 58 Y Xu (496_CR100) 2020; 128 S Stahlman (496_CR80) 2019; 26 E Gould (496_CR39) 2009; 117 R Azziz (496_CR6) 2004; 89 CDC (496_CR21) 2020 496_CR85 SM Bartell (496_CR12) 2010; 118 496_CR87 496_CR88 496_CR89 LG Kahn (496_CR54) 2021; 27 MJ Kim (496_CR55) 2018; 13 J Malits (496_CR66) 2018; 221 SM Bartell (496_CR11) 2021; 71 P Grandjean (496_CR41) 2012; 307 GM Buck Louis (496_CR15) 2012; 23 CE Kormos (496_CR57) 2014; 36 Q Meng (496_CR68) 2018; 15 496_CR90 CC Bach (496_CR10) 2016; 46 496_CR91 LG Kahn (496_CR53) 2020; 8 496_CR13 A Chohan (496_CR26) 2020 MJ Fuldeore (496_CR35) 2017; 82 P Liu (496_CR65) 2018 496_CR16 S Williams (496_CR99) 2018 496_CR19 K Steenland (496_CR83) 2020; 145 G Waterfield (496_CR94) 2020; 19 M Fuldeore (496_CR36) 2015; 103 X Zhou (496_CR102) 2013; 45 496_CR20 496_CR22 496_CR23 J Lam (496_CR60) 2014; 122 496_CR24 P Grandjean (496_CR40) 2015; 25 DQ Andrews (496_CR2) 2020; 7 496_CR25 TM Attina (496_CR4) 2016; 4 J Boivin (496_CR14) 2007; 22 S Crawford (496_CR28) 2016; 105 MLY Wan (496_CR93) 2021 L Lamerato (496_CR61) 2006; 106 LL Wen (496_CR95) 2013; 98 SM Eick (496_CR31) 2020; 9 PI Johnson (496_CR52) 2014; 122 J Holzer (496_CR47) 2008; 116 A Garmendia Madariaga (496_CR37) 2014; 99 SA Missmer (496_CR69) 2004; 160 496_CR32 KE Pelch (496_CR74) 2019; 130 C Peterson (496_CR75) 2015; 212 KM Rappazzo (496_CR76) 2017; 14 KW Whitworth (496_CR97) 2012; 23 P Muennig (496_CR70) 2006; 96 496_CR42 496_CR43 M Wielsoe (496_CR98) 2017; 16 TM Attina (496_CR5) 2019; 108 Z Hepp (496_CR44) 2021; 24 G Liu (496_CR64) 2018; 15 496_CR48 D Schrenk (496_CR78) 2020; 18 ML Levin (496_CR63) 1953; 9 A Impinen (496_CR49) 2019; 124 G Goldenman (496_CR38) 2019 BC Crone (496_CR29) 2019; 49 S Tong (496_CR86) 2018; 18 R Azziz (496_CR7) 2005; 90 E Koustas (496_CR58) 2014; 122 GW Olsen (496_CR73) 2007; 68 CD Fryar (496_CR34) 2016 C Zhang (496_CR101) 2015; 103 K Steenland (496_CR81) 2021; 194 Q Sun (496_CR84) 2018; 126 MJ Knol (496_CR56) 2012; 184 SJ Vagi (496_CR92) 2014; 14 |
| References_xml | – volume: 194 year: 2021 ident: CR81 article-title: PFAS and cancer, a scoping review of the epidemiologic evidence publication-title: Environ Res doi: 10.1016/j.envres.2020.110690 – volume: 98 start-page: E1456 year: 2013 end-page: 1464 ident: CR95 article-title: Association between serum perfluorinated chemicals and thyroid function in U.S. adults: the national health and nutrition examination survey 2007–2010 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2013-1282 – ident: CR22 – volume: 103 start-page: 184 year: 2015 end-page: 189 ident: CR101 article-title: A prospective study of prepregnancy serum concentrations of perfluorochemicals and the risk of gestational diabetes publication-title: Fertil Steril doi: 10.1016/j.fertnstert.2014.10.001 – ident: CR16 – volume: 103 start-page: 163 year: 2015 end-page: 171 ident: CR36 article-title: Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases publication-title: Fertil Steril doi: 10.1016/j.fertnstert.2014.10.011 – volume: 124 start-page: 462 year: 2019 end-page: 472 ident: CR49 article-title: Maternal levels of perfluoroalkyl substances (PFASS) during pregnancy and childhood allergy and asthma related outcomes and infections in the norwegian mother and child (MoBa) cohort publication-title: Environ Int doi: 10.1016/j.envint.2018.12.041 – volume: 17 start-page: 9 year: 2018 ident: CR62 article-title: Prenatal exposure to persistent organic pollutants and child overweight/obesity at 5-year follow-up: a prospective cohort study publication-title: Environ Health doi: 10.1186/s12940-017-0338-x – volume: 160 start-page: 784 year: 2004 end-page: 796 ident: CR69 article-title: Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors publication-title: Am J Epidemiol doi: 10.1093/aje/kwh275 – volume: 46 start-page: 735 year: 2016 end-page: 755 ident: CR10 article-title: Perfluoroalkyl and polyfluoroalkyl substances and measures of human fertility: a systematic review publication-title: Crit Rev Toxicol doi: 10.1080/10408444.2016.1182117 – year: 2021 ident: CR93 article-title: Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies publication-title: Crit Rev Food Sci Nutr doi: 10.1080/10408398.2021.1903382 – ident: CR25 – volume: 117 start-page: 1162 year: 2009 end-page: 1167 ident: CR39 article-title: Childhood lead poisoning: conservative estimates of the social and economic benefits of lead hazard control publication-title: Environ Health Perspect doi: 10.1289/ehp.0800408 – ident: CR42 – volume: 130 year: 2019 ident: CR74 article-title: PFAS health effects database: protocol for a systematic evidence map publication-title: Environ Int doi: 10.1016/j.envint.2019.05.045 – volume: 118 start-page: 222 year: 2010 end-page: 228 ident: CR12 article-title: Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia publication-title: Environ Health Perspect doi: 10.1289/ehp.0901252 – ident: CR19 – volume: 25 start-page: 147 year: 2015 end-page: 163 ident: CR40 article-title: Perfluorinated alkyl substances: emerging insights into health risks publication-title: New Solut doi: 10.1177/1048291115590506 – volume: 216 start-page: 184 year: 2013 end-page: 194 ident: CR3 article-title: Umbilical cord blood levels of perfluoroalkyl acids and polybrominated flame retardants publication-title: Int J Hyg Environ Health doi: 10.1016/j.ijheh.2012.03.004 – volume: 128 start-page: 77004 year: 2020 ident: CR100 article-title: Serum half-lives for short- and long-chain perfluoroalkyl acids after ceasing exposure from drinking water contaminated by firefighting foam publication-title: Environ Health Perspect doi: 10.1289/EHP6785 – volume: 15 year: 2018 ident: CR64 article-title: Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: a prospective study publication-title: PLoS Med doi: 10.1371/journal.pmed.1002502 – ident: CR88 – year: 2020 ident: CR21 publication-title: National diabetes statistics report, 2020: estimates of diabetes and its burden in the United States – volume: 82 start-page: 453 year: 2017 end-page: 461 ident: CR35 article-title: Prevalence and symptomatic burden of diagnosed endometriosis in the United States: national estimates from a cross-sectional survey of 59,411 women publication-title: Gynecol Obstet Investig doi: 10.1159/000452660 – ident: CR85 – volume: 133 start-page: 854 year: 2014 end-page: 862 ident: CR33 article-title: Lifetime direct medical costs of childhood obesity publication-title: Pediatrics doi: 10.1542/peds.2014-0063 – volume: 99 start-page: 923 year: 2014 end-page: 931 ident: CR37 article-title: The incidence and prevalence of thyroid dysfunction in europe: a meta-analysis publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2013-2409 – ident: CR91 – ident: CR72 – volume: 7 start-page: 931 year: 2020 end-page: 936 ident: CR2 article-title: Population-wide exposure to per- and polyfluoroalkyl substances from drinking water in the United States publication-title: Environ Sci Technol Lett doi: 10.1021/acs.estlett.0c00713 – ident: CR89 – volume: 24 start-page: 440 year: 2021 end-page: 446 ident: CR44 article-title: The direct and indirect economic burden of hypothyroidism in the United States: a retrospective claims database study publication-title: J Med Econ doi: 10.1080/13696998.2021.1900202 – volume: 29 start-page: 765 year: 2018 end-page: 776 ident: CR82 article-title: Serum perfluorooctanoic acid and birthweight: an updated meta-analysis with bias analysis publication-title: Epidemiology doi: 10.1097/EDE.0000000000000903 – volume: 15 start-page: 1832 issue: 9 year: 2018 ident: CR68 article-title: Prenatal exposure to perfluoroalkyl substances and birth outcomes; an updated analysis from the Danish National Birth Cohort publication-title: Int J Environ Rese Public Health doi: 10.3390/ijerph15091832 – volume: 122 start-page: 1028 year: 2014 end-page: 1039 ident: CR52 article-title: The navigation guide—evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth publication-title: Environ Health Perspect doi: 10.1289/ehp.1307893 – volume: 89 start-page: 2745 year: 2004 end-page: 2749 ident: CR6 article-title: The prevalence and features of the polycystic ovary syndrome in an unselected population publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2003-032046 – volume: 16 start-page: 56 year: 2017 ident: CR98 article-title: Serum levels of environmental pollutants is a risk factor for breast cancer in inuit: a case control study publication-title: Environ Health doi: 10.1186/s12940-017-0269-6 – year: 1981 ident: CR50 publication-title: Costs of environment-related health effects: a plan for continuing study – volume: 108 start-page: 34 year: 2019 end-page: 43 ident: CR5 article-title: Racial/ethnic disparities in disease burden and costs related to exposure to endocrine-disrupting chemicals in the United States: an exploratory analysis publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2018.11.024 – volume: 71 start-page: 663 year: 2021 end-page: 679 ident: CR11 article-title: Critical review on pfoa, kidney cancer, and testicular cancer publication-title: J Air Waste Manag Assoc doi: 10.1080/10962247.2021.1909668 – year: 2019 ident: CR38 publication-title: The cost of inaction: a socioeconomic analysis of environmental and health impacts linked to exposure to PFAS doi: 10.6027/TN2019-516 – volume: 145 year: 2020 ident: CR83 article-title: Review: evolution of evidence on PFOA and health following the assessments of the C8 Science Panel publication-title: Environ Int doi: 10.1016/j.envint.2020.106125 – volume: 37 start-page: 1495 year: 2019 end-page: 1507 ident: CR79 article-title: Rising economic burden of renal cell carcinoma among elderly patients in the USA: part II—an updated analysis of SEER-Medicare Data publication-title: Pharmacoeconomics doi: 10.1007/s40273-019-00824-2 – volume: 115 start-page: 1596 year: 2007 end-page: 1602 ident: CR17 article-title: Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and comparisons with NHANES 1999–2000 publication-title: Environ Health Perspect doi: 10.1289/ehp.10598 – year: 2018 ident: CR65 article-title: Perfluorooctanoic acid (PFOA) exposure in early life increases risk of childhood adiposity: a meta-analysis of prospective cohort studies publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph15102070 – ident: CR13 – volume: 49 start-page: 2359 year: 2019 end-page: 2396 ident: CR29 article-title: Occurrence of per- and polyfluoroalkyl substances (PFAS) in source water and their treatment in drinking water publication-title: Crit Rev Environ Sci Technol doi: 10.1080/10643389.2019.1614848 – year: 2018 ident: CR99 publication-title: National hospital care survey demonstration projects: pneumonia inpatient hospitalizations and emergency department visits (National Health Statistics Reports) – ident: CR24 – volume: 90 start-page: 4650 year: 2005 end-page: 4658 ident: CR7 article-title: Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2005-0628 – volume: 58 start-page: 295 year: 1965 end-page: 300 ident: CR45 article-title: The environment and disease: association or causation? publication-title: Proc R Soc Med – volume: 8 start-page: 703 year: 2020 end-page: 718 ident: CR53 article-title: Endocrine-disrupting chemicals: implications for human health publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(20)30129-7 – volume: 3 start-page: 1629 year: 2014 end-page: 1634 ident: CR1 article-title: Testicular self-examination and testicular cancer: a cost-utility analysis publication-title: Cancer Med doi: 10.1002/cam4.318 – volume: 19 start-page: 42 year: 2020 ident: CR94 article-title: Reducing exposure to high levels of perfluorinated compounds in drinking water improves reproductive outcomes: evidence from an intervention in Minnesota publication-title: Environ Health doi: 10.1186/s12940-020-00591-0 – ident: CR87 – volume: 372 start-page: 835 year: 2015 end-page: 845 ident: CR51 article-title: Community-acquired pneumonia requiring hospitalization among U.S. Children publication-title: N Engl J Med doi: 10.1056/NEJMoa1405870 – volume: 371 start-page: 796 year: 2014 end-page: 797 ident: CR71 article-title: Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY Threshold publication-title: N Engl J Med doi: 10.1056/NEJMp1405158 – volume: 45 start-page: 53 year: 2015 end-page: 67 ident: CR8 article-title: Perfluoroalkyl and polyfluoroalkyl substances and human fetal growth: a systematic review publication-title: Crit Rev Toxicol doi: 10.3109/10408444.2014.952400 – volume: 212 start-page: e71 issue: 74 year: 2015 end-page: 79 ident: CR75 article-title: Preventable health and cost burden of adverse birth outcomes associated with pregestational diabetes in the United States publication-title: Am J Obstet Gynecol – volume: 4 start-page: 996 year: 2016 end-page: 1003 ident: CR4 article-title: Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(16)30275-3 – volume: 18 year: 2020 ident: CR78 article-title: Risk to human health related to the presence of perfluoroalkyl substances in food publication-title: EFSA J Eur Food Saf Auth – year: 2011 ident: CR59 publication-title: Hospital stays for newborns – ident: CR67 – volume: 9 start-page: 249 year: 2020 ident: CR31 article-title: Assessing risk of bias in human environmental epidemiology studies using three tools: different conclusions from different tools publication-title: Syst Rev doi: 10.1186/s13643-020-01490-8 – ident: CR32 – volume: 13 year: 2018 ident: CR55 article-title: Association between perfluoroalkyl substances exposure and thyroid function in adults: a meta-analysis publication-title: PLoS ONE doi: 10.1371/journal.pone.0197244 – year: 2020 ident: CR26 article-title: Per and polyfluoroalkyl substances scientific literature review: water exposure, impact on human health, and implications for regulatory reform publication-title: Rev Environ Health doi: 10.1515/reveh-2020-0049 – volume: 45 start-page: 253 year: 2013 end-page: 261 ident: CR102 article-title: Lifetime direct medical costs of treating type 2 diabetes and diabetic complications publication-title: Am J Prev Med doi: 10.1016/j.amepre.2013.04.017 – volume: 27 start-page: 339 year: 2021 end-page: 366 ident: CR54 article-title: Persistent organic pollutants and couple fecundability: a systematic review publication-title: Hum Reprod Update doi: 10.1093/humupd/dmaa037 – volume: 9 start-page: 531 year: 1953 end-page: 541 ident: CR63 article-title: The occurrence of lung cancer in man publication-title: Acta Unio Int Contra Cancrum – volume: 23 start-page: 799 year: 2012 end-page: 805 ident: CR15 article-title: Perfluorochemicals and endometriosis: the ENDO Study publication-title: Epidemiology doi: 10.1097/EDE.0b013e31826cc0cf – volume: 55 start-page: 9630 year: 2021 end-page: 9633 ident: CR27 article-title: The true cost of pfas and the benefits of acting now publication-title: Environ Sci Technol doi: 10.1021/acs.est.1c03565 – volume: 307 start-page: 391 year: 2012 end-page: 397 ident: CR41 article-title: Serum vaccine antibody concentrations in children exposed to perfluorinated compounds publication-title: JAMA doi: 10.1001/jama.2011.2034 – volume: 22 start-page: 1506 year: 2007 end-page: 1512 ident: CR14 article-title: International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care publication-title: Hum Reprod doi: 10.1093/humrep/dem046 – ident: CR43 – volume: 116 start-page: 651 year: 2008 end-page: 657 ident: CR47 article-title: Biomonitoring of perfluorinated compounds in children and adults exposed to perfluorooctanoate-contaminated drinking water publication-title: Environ Health Perspect doi: 10.1289/ehp.11064 – volume: 14 start-page: 691 issue: 7 year: 2017 ident: CR76 article-title: Exposure to perfluorinated alkyl substances and health outcomes in children: a systematic review of the epidemiologic literature publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph14070691 – volume: 69 start-page: 225 year: 2016 end-page: 234 ident: CR96 article-title: Robis: a new tool to assess risk of bias in systematic reviews was developed publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2015.06.005 – volume: 105 start-page: 444 year: 2016 end-page: 450 ident: CR28 article-title: Costs of achieving live birth from assisted reproductive technology: a comparison of sequential single and double embryo transfer approaches publication-title: Fertil Steril doi: 10.1016/j.fertnstert.2015.10.032 – year: 2017 ident: CR30 publication-title: Epidemiological investigation and economic analysis of polycystic ovary syndrome (PCOS) for women in the UK – year: 2016 ident: CR34 publication-title: Prevalence of overweight, obesity, and extreme obesity among adults aged 20 and over: United states, 1960–1962 through 2013–2014 – volume: 36 start-page: 213 year: 2014 end-page: 224 ident: CR57 article-title: Low birth weight and intelligence in adolescence and early adulthood: a meta-analysis publication-title: J Public Health (oxf) doi: 10.1093/pubmed/fdt071 – volume: 96 start-page: 1662 year: 2006 end-page: 1668 ident: CR70 article-title: Gender and the burden of disease attributable to obesity publication-title: Am J Public Health doi: 10.2105/AJPH.2005.068874 – volume: 31 start-page: 219 year: 2012 end-page: 230 ident: CR18 article-title: The medical care costs of obesity: an instrumental variables approach publication-title: J Health Econ doi: 10.1016/j.jhealeco.2011.10.003 – volume: 14 start-page: 86 year: 2014 ident: CR92 article-title: Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol a in polycystic ovary syndrome: a case–control study publication-title: BMC Endocr Disord doi: 10.1186/1472-6823-14-86 – volume: 31 start-page: 961 year: 2021 end-page: 971 ident: CR77 article-title: Advancing per- and polyfluoroalkyl substances (PFAS) research: an overview of ATSDR and NCEH activities and recommendations publication-title: J Expo Sci Environ Epidemiol doi: 10.1038/s41370-021-00316-6 – ident: CR23 – volume: 106 start-page: 1875 year: 2006 end-page: 1882 ident: CR61 article-title: Economic burden associated with breast cancer recurrence: findings from a retrospective analysis of health system data publication-title: Cancer doi: 10.1002/cncr.21824 – volume: 124 start-page: 848 year: 2016 end-page: 854 ident: CR9 article-title: Perfluoroalkyl acids in maternal serum and indices of fetal growth: the Aarhus Birth Cohort publication-title: Environ Health Perspect doi: 10.1289/ehp.1510046 – volume: 184 start-page: 895 year: 2012 end-page: 899 ident: CR56 article-title: Overestimation of risk ratios by odds ratios in trials and cohort studies: alternatives to logistic regression publication-title: CMAJ doi: 10.1503/cmaj.101715 – volume: 122 start-page: 1040 year: 2014 end-page: 1051 ident: CR60 article-title: The navigation guide—evidence-based medicine meets environmental health: integration of animal and human evidence for PFOA effects on fetal growth publication-title: Environ Health Perspect doi: 10.1289/ehp.1307923 – ident: CR48 – volume: 122 start-page: 1015 year: 2014 end-page: 1027 ident: CR58 article-title: The navigation guide—evidence-based medicine meets environmental health: systematic review of nonhuman evidence for PFOA effects on fetal growth publication-title: Environ Health Perspect doi: 10.1289/ehp.1307177 – ident: CR90 – volume: 68 start-page: 105 year: 2007 end-page: 111 ident: CR73 article-title: Preliminary evidence of a decline in perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations in American Red Cross blood donors publication-title: Chemosphere doi: 10.1016/j.chemosphere.2006.12.031 – volume: 23 start-page: 257 year: 2012 end-page: 263 ident: CR97 article-title: Perfluorinated compounds and subfecundity in pregnant women publication-title: Epidemiology doi: 10.1097/EDE.0b013e31823b5031 – volume: 26 start-page: 20 year: 2019 end-page: 27 ident: CR80 article-title: Female infertility, active component service women, U.S. Armed forces, 2013–2018 publication-title: MSMR – volume: 18 start-page: 715 year: 2018 ident: CR86 article-title: Trends in healthcare utilization and costs associated with pneumonia in the United States during 2008–2014 publication-title: BMC Health Serv Res doi: 10.1186/s12913-018-3529-4 – volume: 221 start-page: 269 year: 2018 end-page: 275 ident: CR66 article-title: Perfluorooctanoic acid and low birth weight: estimates of us attributable burden and economic costs from 2003 through 2014 publication-title: Int J Hyg Environ Health doi: 10.1016/j.ijheh.2017.11.004 – volume: 87 start-page: 489 year: 2002 end-page: 499 ident: CR46 article-title: Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III) publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem.87.2.8182 – volume: 126 start-page: 037001 year: 2018 ident: CR84 article-title: Plasma concentrations of perfluoroalkyl substances and risk of type 2 diabetes: a prospective investigation among U.S. women publication-title: Environ Health Perspect doi: 10.1289/EHP2619 – ident: CR20 – volume: 36 start-page: 213 year: 2014 ident: 496_CR57 publication-title: J Public Health (oxf) doi: 10.1093/pubmed/fdt071 – volume: 29 start-page: 765 year: 2018 ident: 496_CR82 publication-title: Epidemiology doi: 10.1097/EDE.0000000000000903 – volume: 18 start-page: 715 year: 2018 ident: 496_CR86 publication-title: BMC Health Serv Res doi: 10.1186/s12913-018-3529-4 – ident: 496_CR67 – ident: 496_CR91 – volume: 69 start-page: 225 year: 2016 ident: 496_CR96 publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2015.06.005 – ident: 496_CR87 – volume: 145 year: 2020 ident: 496_CR83 publication-title: Environ Int doi: 10.1016/j.envint.2020.106125 – volume: 184 start-page: 895 year: 2012 ident: 496_CR56 publication-title: CMAJ doi: 10.1503/cmaj.101715 – volume: 15 year: 2018 ident: 496_CR64 publication-title: PLoS Med doi: 10.1371/journal.pmed.1002502 – volume: 90 start-page: 4650 year: 2005 ident: 496_CR7 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2005-0628 – volume: 14 start-page: 86 year: 2014 ident: 496_CR92 publication-title: BMC Endocr Disord doi: 10.1186/1472-6823-14-86 – ident: 496_CR24 – volume: 45 start-page: 53 year: 2015 ident: 496_CR8 publication-title: Crit Rev Toxicol doi: 10.3109/10408444.2014.952400 – volume: 115 start-page: 1596 year: 2007 ident: 496_CR17 publication-title: Environ Health Perspect doi: 10.1289/ehp.10598 – volume: 82 start-page: 453 year: 2017 ident: 496_CR35 publication-title: Gynecol Obstet Investig doi: 10.1159/000452660 – volume: 87 start-page: 489 year: 2002 ident: 496_CR46 publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem.87.2.8182 – volume: 9 start-page: 531 year: 1953 ident: 496_CR63 publication-title: Acta Unio Int Contra Cancrum – year: 2021 ident: 496_CR93 publication-title: Crit Rev Food Sci Nutr doi: 10.1080/10408398.2021.1903382 – volume: 23 start-page: 799 year: 2012 ident: 496_CR15 publication-title: Epidemiology doi: 10.1097/EDE.0b013e31826cc0cf – volume: 103 start-page: 163 year: 2015 ident: 496_CR36 publication-title: Fertil Steril doi: 10.1016/j.fertnstert.2014.10.011 – volume: 9 start-page: 249 year: 2020 ident: 496_CR31 publication-title: Syst Rev doi: 10.1186/s13643-020-01490-8 – volume: 99 start-page: 923 year: 2014 ident: 496_CR37 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2013-2409 – volume: 117 start-page: 1162 year: 2009 ident: 496_CR39 publication-title: Environ Health Perspect doi: 10.1289/ehp.0800408 – volume: 122 start-page: 1028 year: 2014 ident: 496_CR52 publication-title: Environ Health Perspect doi: 10.1289/ehp.1307893 – volume: 194 year: 2021 ident: 496_CR81 publication-title: Environ Res doi: 10.1016/j.envres.2020.110690 – volume: 216 start-page: 184 year: 2013 ident: 496_CR3 publication-title: Int J Hyg Environ Health doi: 10.1016/j.ijheh.2012.03.004 – ident: 496_CR42 – volume: 4 start-page: 996 year: 2016 ident: 496_CR4 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(16)30275-3 – volume: 307 start-page: 391 year: 2012 ident: 496_CR41 publication-title: JAMA doi: 10.1001/jama.2011.2034 – volume: 126 start-page: 037001 year: 2018 ident: 496_CR84 publication-title: Environ Health Perspect doi: 10.1289/EHP2619 – volume: 17 start-page: 9 year: 2018 ident: 496_CR62 publication-title: Environ Health doi: 10.1186/s12940-017-0338-x – volume: 18 year: 2020 ident: 496_CR78 publication-title: EFSA J Eur Food Saf Auth – volume-title: Epidemiological investigation and economic analysis of polycystic ovary syndrome (PCOS) for women in the UK year: 2017 ident: 496_CR30 – volume: 16 start-page: 56 year: 2017 ident: 496_CR98 publication-title: Environ Health doi: 10.1186/s12940-017-0269-6 – ident: 496_CR13 – volume: 7 start-page: 931 year: 2020 ident: 496_CR2 publication-title: Environ Sci Technol Lett doi: 10.1021/acs.estlett.0c00713 – volume: 31 start-page: 961 year: 2021 ident: 496_CR77 publication-title: J Expo Sci Environ Epidemiol doi: 10.1038/s41370-021-00316-6 – volume-title: The cost of inaction: a socioeconomic analysis of environmental and health impacts linked to exposure to PFAS year: 2019 ident: 496_CR38 doi: 10.6027/TN2019-516 – volume-title: Prevalence of overweight, obesity, and extreme obesity among adults aged 20 and over: United states, 1960–1962 through 2013–2014 year: 2016 ident: 496_CR34 – volume: 55 start-page: 9630 year: 2021 ident: 496_CR27 publication-title: Environ Sci Technol doi: 10.1021/acs.est.1c03565 – year: 2020 ident: 496_CR26 publication-title: Rev Environ Health doi: 10.1515/reveh-2020-0049 – volume: 98 start-page: E1456 year: 2013 ident: 496_CR95 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2013-1282 – ident: 496_CR22 – volume: 25 start-page: 147 year: 2015 ident: 496_CR40 publication-title: New Solut doi: 10.1177/1048291115590506 – volume: 105 start-page: 444 year: 2016 ident: 496_CR28 publication-title: Fertil Steril doi: 10.1016/j.fertnstert.2015.10.032 – volume-title: Hospital stays for newborns year: 2011 ident: 496_CR59 – volume: 122 start-page: 1040 year: 2014 ident: 496_CR60 publication-title: Environ Health Perspect doi: 10.1289/ehp.1307923 – ident: 496_CR16 – ident: 496_CR89 – volume: 89 start-page: 2745 year: 2004 ident: 496_CR6 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2003-032046 – volume: 128 start-page: 77004 year: 2020 ident: 496_CR100 publication-title: Environ Health Perspect doi: 10.1289/EHP6785 – ident: 496_CR72 – ident: 496_CR48 – volume: 130 year: 2019 ident: 496_CR74 publication-title: Environ Int doi: 10.1016/j.envint.2019.05.045 – volume: 24 start-page: 440 year: 2021 ident: 496_CR44 publication-title: J Med Econ doi: 10.1080/13696998.2021.1900202 – ident: 496_CR19 – volume: 96 start-page: 1662 year: 2006 ident: 496_CR70 publication-title: Am J Public Health doi: 10.2105/AJPH.2005.068874 – volume: 122 start-page: 1015 year: 2014 ident: 496_CR58 publication-title: Environ Health Perspect doi: 10.1289/ehp.1307177 – volume: 124 start-page: 848 year: 2016 ident: 496_CR9 publication-title: Environ Health Perspect doi: 10.1289/ehp.1510046 – volume: 22 start-page: 1506 year: 2007 ident: 496_CR14 publication-title: Hum Reprod doi: 10.1093/humrep/dem046 – ident: 496_CR25 – volume: 68 start-page: 105 year: 2007 ident: 496_CR73 publication-title: Chemosphere doi: 10.1016/j.chemosphere.2006.12.031 – ident: 496_CR20 – ident: 496_CR90 – volume: 108 start-page: 34 year: 2019 ident: 496_CR5 publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2018.11.024 – volume: 106 start-page: 1875 year: 2006 ident: 496_CR61 publication-title: Cancer doi: 10.1002/cncr.21824 – volume: 3 start-page: 1629 year: 2014 ident: 496_CR1 publication-title: Cancer Med doi: 10.1002/cam4.318 – volume: 58 start-page: 295 year: 1965 ident: 496_CR45 publication-title: Proc R Soc Med – ident: 496_CR88 – volume: 71 start-page: 663 year: 2021 ident: 496_CR11 publication-title: J Air Waste Manag Assoc doi: 10.1080/10962247.2021.1909668 – volume: 46 start-page: 735 year: 2016 ident: 496_CR10 publication-title: Crit Rev Toxicol doi: 10.1080/10408444.2016.1182117 – volume: 27 start-page: 339 year: 2021 ident: 496_CR54 publication-title: Hum Reprod Update doi: 10.1093/humupd/dmaa037 – volume: 13 year: 2018 ident: 496_CR55 publication-title: PLoS ONE doi: 10.1371/journal.pone.0197244 – volume: 133 start-page: 854 year: 2014 ident: 496_CR33 publication-title: Pediatrics doi: 10.1542/peds.2014-0063 – volume-title: National hospital care survey demonstration projects: pneumonia inpatient hospitalizations and emergency department visits (National Health Statistics Reports) year: 2018 ident: 496_CR99 – ident: 496_CR23 – volume-title: Costs of environment-related health effects: a plan for continuing study year: 1981 ident: 496_CR50 – volume: 23 start-page: 257 year: 2012 ident: 496_CR97 publication-title: Epidemiology doi: 10.1097/EDE.0b013e31823b5031 – volume: 372 start-page: 835 year: 2015 ident: 496_CR51 publication-title: N Engl J Med doi: 10.1056/NEJMoa1405870 – volume: 31 start-page: 219 year: 2012 ident: 496_CR18 publication-title: J Health Econ doi: 10.1016/j.jhealeco.2011.10.003 – volume: 221 start-page: 269 year: 2018 ident: 496_CR66 publication-title: Int J Hyg Environ Health doi: 10.1016/j.ijheh.2017.11.004 – volume: 212 start-page: e71 issue: 74 year: 2015 ident: 496_CR75 publication-title: Am J Obstet Gynecol – ident: 496_CR32 – volume: 26 start-page: 20 year: 2019 ident: 496_CR80 publication-title: MSMR – volume: 49 start-page: 2359 year: 2019 ident: 496_CR29 publication-title: Crit Rev Environ Sci Technol doi: 10.1080/10643389.2019.1614848 – volume: 45 start-page: 253 year: 2013 ident: 496_CR102 publication-title: Am J Prev Med doi: 10.1016/j.amepre.2013.04.017 – volume: 116 start-page: 651 year: 2008 ident: 496_CR47 publication-title: Environ Health Perspect doi: 10.1289/ehp.11064 – volume: 124 start-page: 462 year: 2019 ident: 496_CR49 publication-title: Environ Int doi: 10.1016/j.envint.2018.12.041 – volume: 371 start-page: 796 year: 2014 ident: 496_CR71 publication-title: N Engl J Med doi: 10.1056/NEJMp1405158 – ident: 496_CR85 – volume-title: National diabetes statistics report, 2020: estimates of diabetes and its burden in the United States year: 2020 ident: 496_CR21 – volume: 8 start-page: 703 year: 2020 ident: 496_CR53 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(20)30129-7 – ident: 496_CR43 – volume: 160 start-page: 784 year: 2004 ident: 496_CR69 publication-title: Am J Epidemiol doi: 10.1093/aje/kwh275 – volume: 19 start-page: 42 year: 2020 ident: 496_CR94 publication-title: Environ Health doi: 10.1186/s12940-020-00591-0 – volume: 15 start-page: 1832 issue: 9 year: 2018 ident: 496_CR68 publication-title: Int J Environ Rese Public Health doi: 10.3390/ijerph15091832 – volume: 37 start-page: 1495 year: 2019 ident: 496_CR79 publication-title: Pharmacoeconomics doi: 10.1007/s40273-019-00824-2 – year: 2018 ident: 496_CR65 publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph15102070 – volume: 103 start-page: 184 year: 2015 ident: 496_CR101 publication-title: Fertil Steril doi: 10.1016/j.fertnstert.2014.10.001 – volume: 118 start-page: 222 year: 2010 ident: 496_CR12 publication-title: Environ Health Perspect doi: 10.1289/ehp.0901252 – volume: 14 start-page: 691 issue: 7 year: 2017 ident: 496_CR76 publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph14070691 |
| SSID | ssj0001651124 ssib033405581 |
| Score | 2.4444454 |
| Snippet | Accelerating evidence confirms the contribution of per- and polyfluoroalkyl substances (PFAS) to disease burden and disability across the lifespan. Given that... |
| SourceID | pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 373 |
| SubjectTerms | Aquatic Pollution Bans Consumer products Cost analysis Costs Diabetes Disease Drinking water Earth and Environmental Science Economic impact Economics Endocrine disruptors Environment Environmental Health Environmental protection Exposure Fertility Food contamination & poisoning Food packaging Health services Hyperlipidemia Hypothyroidism Infertility Inflammatory bowel disease Kidney cancer Life span Lower bounds Mathematical analysis Meta-analysis Obesity Original Paper Perfluoroalkyl & polyfluoroalkyl substances Perfluorochemicals Perfluorooctane sulfonic acid Perfluorooctanoic acid Pollution Prenatal exposure Public health Sensitivity analysis Systematic review Testicular cancer Thyroid gland Waste Water Technology Water and Health Water Management Water Pollution Control Water Quality/Water Pollution |
| SummonAdditionalLinks | – databaseName: Biological Science Database dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagIIFU8SiPphRkJG5gEcdeJzlVqFBxQNVKgNRb5HjH6oooLpss0v4BfjceO8lqqeiFWx5ONs6MJ9_O4xtC3gi1gMLqmtmymDGplWJag2G5goLnVmSpsqHZRH5-XlxclPPB4dYNaZWjTQyGeuEM-sjfY1elDGl45MnVT4ZdozC6OrTQuE3uIEuCCKl781GfhPBoZKT3Cj4XhfACA82ZxO7yuVJDHU2spkNuOobp7YibFdvsfquuAdDreZR_BVPDN-rs4f_O7hF5MKBT-iGq02NyC9oDcm8sXu4OyH5089FYvfSE_P4Cfi2ETkf060QKTWPEoaO9ozHJD-jHGAmisW6C6nZBT13Xd9RZOocVC0fmrtnYZu1WTjc_Ng1Fs9ajXuJtHDozO7psqQetNIJlGsHyU_L97NO3089saO3AzEzynoEVkHILMDO2zLnmJjUCLJTS1Mb4_dryuqwFV6VRGj0MCCTSWivAuCSIZ2SvdS0cEmplaqRSswyAy0ybstB1ni7AWCkzw8uE8FGIlRl4z7H9RlNtGZtR8JUXfBUEX20S8na65iqyftw4-ngUajVYgK7aSjQhr6fTfu1iQEa34NZ-jF8Oee4BepaQ51GVpp8T_q-58MY0IcWOkk0DkBd890y7vAz84P51lUUh_U3fjfq4fa5_T-Po5mm8IPdxM6bJHZO9frWGl-Su-dUvu9WrsPD-AFNKNKQ priority: 102 providerName: ProQuest |
| Title | Leveraging Systematic Reviews to Explore Disease Burden and Costs of Per- and Polyfluoroalkyl Substance Exposures in the United States |
| URI | https://link.springer.com/article/10.1007/s12403-022-00496-y https://www.ncbi.nlm.nih.gov/pubmed/37213870 https://www.proquest.com/docview/2920237384 https://www.proquest.com/docview/2817779162 https://pubmed.ncbi.nlm.nih.gov/PMC10198842 |
| Volume | 15 |
| WOSCitedRecordID | wos000831008200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2451-9685 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0001651124 issn: 2451-9766 databaseCode: M7P dateStart: 20090201 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Earth, Atmospheric & Aquatic Science Database customDbUrl: eissn: 2451-9685 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0001651124 issn: 2451-9766 databaseCode: PCBAR dateStart: 20090201 isFulltext: true titleUrlDefault: https://search.proquest.com/eaasdb providerName: ProQuest – providerCode: PRVPQU databaseName: Environmental Science Database customDbUrl: eissn: 2451-9685 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0001651124 issn: 2451-9766 databaseCode: PATMY dateStart: 20090201 isFulltext: true titleUrlDefault: http://search.proquest.com/environmentalscience providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2451-9685 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0001651124 issn: 2451-9766 databaseCode: BENPR dateStart: 20090201 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 2451-9685 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0001651124 issn: 2451-9766 databaseCode: 8C1 dateStart: 20090201 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 2451-9685 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001651124 issn: 2451-9766 databaseCode: RSV dateStart: 20160101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9MwELXYXQ5IiO-PwFIZiRtEimPXcY5L2RUHtop2F1ROkeOORUWUoCZF6h_gd-OJk1RlAQkukRq7Tu0-2y-emTeEvOJyCcrqIrSpmoZCSxlqDSZMJCiWWB5H0nbJJpL5XC0WadYHhTWDt_tgkuxW6l2wG0rHheh9jrRWhtsDcuS2O4XT8eLy04Aizh0HGUS9upMWiaQCzcuxwJzyiZR99Mzvm93foa7Rzuvek7-YULud6ezu__XpHrnTM1F64qFzn9yA6gG57Y_xqI9Oekh-fACH9S6TEb0cRZ-ptyg0tK2pd-ID-s5beqiPi6C6WtJZ3bQNrS3NYB12d7K63NpyU69rXX7dlhSXrRZxh83UeFjZ0FVFHSmlngxTT4YfkY9np1ez92GfuiE0U8HaECyHiFmAqbFpwjQzkeFgIRWmMMZ9Liwr0oIzmRqp8QQBiUJUaAlodwT-mBxWdQVPCbUiMkLKaQzARKxNqnSRREswVojYsDQgbPi7ctPrmmN6jTLfKTLjKOdulPNulPNtQF6P3_nmVT3-Wvt4QEHez_AmxyxfMcpCiYC8HIvd3ESDi66g3rg6Du5J4gh4HJAnHjTj47h79eZusQyI2oPTWAF1v_dLqtWXTv_bDVeqlHCNvhlQtftdf-7Gs3-r_pzcwh56t7hjctiuN_CC3DTf21WznpCDZKHcVc3YhBy9PZ1nFxP0m83cdZ6du3vZydX550k3NX8CHjIuoQ |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1fb9MwED-NgTQkxJ_xrzDASPAEFrHjOskDQmhj2rQyVWJIewuOexYVVTKaFNQvwMfhM-KLm1ZlYm974LGJ6ybu7853vrvfAbyI9QhTZwrusrTPldGaG4OWJxpTkbhYRtq1zSaS4-P09DQbbsDvrhaG0io7ndgq6lFl6Yz8DXVVkkTDo96dfefUNYqiq10LjQCLI5z_9C5b_fZwz_-_L6Xc_3Cye8AXXQW47SvRcHQxRsIh9q3LEmGEjWyMDjNlC2v958KJIitioTOrDTm3tIdFhdFIITGM_bxX4Ko3I2TapgoOO_zGsbd-Ojqx9oxHkzlDgW2pqJt9ovWibidU7xEXHqd0erLTNZ-v743nDN7zeZt_BW_bPXH_1v-2mrfh5sL6Zu-DuNyBDSy3Yasrzq634UY4xmShOusu_Bqgl_W2kxP7tCS9ZiGiUrOmYiGJEdleiHSxUBfCTDliu1Xd1KxybIhT3l4ZVpO5m8yqaWUm3-YTRmq7IbmjaSo6rK3ZuGTeKGfBGWDBGbgHny9lWe7DZlmV-BCYU5FVWvclolDS2Cw1RRKN0DqlpBVZD0QHmtwueN2pvcgkXzFSE9ByD7S8BVo-78Gr5XfOAqvJhaN3OhDlCw1X5ysE9eD58rbXTRRwMiVWMz_Gi3uSeAdE9uBBgO7y5-JEithvFj1I10C9HEC85-t3yvHXlv_cL1eWpspP-rrD_-q5_v0ajy5-jWewdXDycZAPDo-PHsN1uhxSAndgs5nO8Alcsz-acT192go9gy-XLRd_AI1ik9I |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fi9QwEA56ihyIvz2rp0bwTcM1TTZtH-XORfFYFk7l3kqaneBiaY5tV9h_wL_bTNN2XU8F8bFNmjbpTPIlM_MNIS-FWkBmdclsnk2Y1EoxrcGwVEHGUyuSWNku2UQ6m2Xn5_n8pyj-ztt9MEmGmAZkaarbo4uFPdoGviGNHENPdIS4im2ukmsSkwbhfv3s8yBRQng8MhB8dacuCgEGmpoTifnlU6X6SJrfN7u7Wl2CoJc9KX8xp3ar1PT2__fvDrnVI1T6JojUXXIF6nvkZjjeoyFq6T75fgpeB7oMR_RsJIOmwdLQ0NbR4NwH9CRYgGiIl6C6XtBj17QNdZbOYcW6O3NXbWy1diunq6-biuJ01qI8YjMODzEbuqypB6s0gGQaQPID8mn69uPxO9andGBmInnLwAqIuQWYGJunXHMTGwEWcmlKY_x1aXmZl4Kr3CiNJwsIIOJSK0B7JIiHZK92NTwi1MrYSKUmCQCXiTZ5pss0XoCxUiaG5xHhw68rTM93jmk3qmLL1IyjXPhRLrpRLjYReTU-cxHYPv5a-3CQiKLX_KbA7F8J0kXJiLwYi73OoiFG1-DWvo5XgzT1wDyJyEEQoPF1wm_JhZ9EI5LtiNZYAfnAd0vq5ZeOF9wPV55l0jf6epCw7Xf9uRuP_636c3JjfjItTt_PPjwh-9jZ4Dl3SPba1RqekuvmW7tsVs86TfwBFFQzaw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Leveraging+Systematic+Reviews+to+Explore+Disease+Burden+and+Costs+of+Per-+and+Polyfluoroalkyl+Substance+Exposures+in+the+United+States&rft.jtitle=Exposure+and+health&rft.au=Obsekov%2C+Vladislav&rft.au=Kahn%2C+Linda+G.&rft.au=Trasande%2C+Leonardo&rft.date=2023-06-01&rft.pub=Springer+Netherlands&rft.issn=2451-9766&rft.eissn=2451-9685&rft.volume=15&rft.issue=2&rft.spage=373&rft.epage=394&rft_id=info:doi/10.1007%2Fs12403-022-00496-y&rft.externalDocID=PMC10198842 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2451-9766&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2451-9766&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2451-9766&client=summon |